Q Bio is a U.S. preventive-health services platform provider. The company has built what it describes as the first clinical digital twin platform and offers medical imaging technology services. Recently Q Bio secured $27 million in a strategic financing. The round brings in a new investor, TELUS Global Ventures. Existing investors participating include Khosla Ventures, Andreessen Horowitz, Founders Fund and Kaiser Foundation Hospitals. The article frames the funding as a strategic expansion of the company’s investor base. Q Bio develops the Q Bio Gemini clinical digital-twin platform and the Mark I self-driving whole-body scanner. Gemini creates a scalable virtual model that reflects an individual’s physiological state and highlights important changes that can be shared with clinicians. The Mark I scans the whole body in 15 minutes or less without radiation, breath holds, or claustrophobia and is optimized for proactive care. The company says its computational biophysics approach is at least 10x faster than conventional MRI without loss of diagnostic quality, enabling cheaper hardware and lower operational costs. Q Bio plans to develop and expand access to its proprietary platform and scanning technologies to enable data-driven, proactive, and more affordable preventive care. Founded in 2015 and based in San Carlos, Calif., the company has raised more than $80 million in capital from a group of investors including Andreessen Horowitz and Kaiser Foundation Hospitals. Q Bio operates a proprietary platform that combines imaging, blood measures and selected biomarkers to produce a quantitative, clinically-relevant assessment of individual health. The company refined its imaging protocols and identified the most clinically relevant biomarkers during a multi-year stealth period. In 75 minutes or less members receive a comprehensive health picture and a web-based dashboard they can share with clinicians. Q Bio quietly opened to a limited membership in late 2019 and says it plans to open additional locations this year. The company was founded in 2015 and is based in Redwood City, California. Its stated mission is to make preventive health faster, better and more affordable so treatable diseases are caught earlier.

Total raised

$67M

Funding rounds

3

Latest round

Equity

Latest activity

Jul 2024